
Caszyme Caszyme was founded in 2017 by the scientists who were among the pioneers demonstrating that CRISPR-Cas9 can be used to generate precise double-stranded DNA breaks. Their discovery helped to enable a new era of gene editing. Caszyme is leveraging CRISPR with its deep gene editing expertise, backed by a novel, highly flexible Cas12l nucleases platform that enables development of world class CRISPR therapeutics and CRISPR based solutions. Therapeutic Developer

Caszyme

Caszyme was founded in 2017 by the scientists who were among the pioneers demonstrating that CRISPR-Cas9 can be used to generate precise double-stranded DNA breaks. Their discovery helped to enable a new era of gene editing. Caszyme is leveraging CRISPR with its deep gene editing expertise, backed by a novel, highly flexible Cas12l nucleases platform that enables development of world class CRISPR therapeutics and CRISPR based solutions.

Therapeutic Developer